zuranolone 30 MG Oral Capsule [Zurzuvae]
- RxCUI
- 2669924
- RxNorm name
- zuranolone 30 MG Oral Capsule [Zurzuvae]
- Display name
- zuranolone 30 MG Oral Capsule [Zurzuvae]
- Full name
- zuranolone 30 MG Oral Capsule [Zurzuvae]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:27
UNII Substances#
No records found.
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ZURZUVAE | ZURANOLONE | Biogen MA Inc. | f18e53b0-d0bb-422d-8de7-ab64b7292b29 | 2026-06-15 | Boxed warning, Warnings, Adverse reactions | 2669924 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| f18e53b0-d0bb-422d-8de7-ab64b7292b29 | zuranolone 30 MG Oral Capsule [Zurzuvae] | SBD | 17 | These highlights do not include all the information needed to use ZURZUVAE safely and effectively. See full prescribing information for ZURZUVAE. ZURZUVAE ® (zuranolone) capsules, for oral use, CIV Initial U.S. Approval: 2023 | 20260421 |
| f18e53b0-d0bb-422d-8de7-ab64b7292b29 | ZURZUVAE 30 MG Oral Capsule | PSN | 17 | These highlights do not include all the information needed to use ZURZUVAE safely and effectively. See full prescribing information for ZURZUVAE. ZURZUVAE ® (zuranolone) capsules, for oral use, CIV Initial U.S. Approval: 2023 | 20260421 |
| f18e53b0-d0bb-422d-8de7-ab64b7292b29 | Zurzuvae 30 MG Oral Capsule | SY | 17 | These highlights do not include all the information needed to use ZURZUVAE safely and effectively. See full prescribing information for ZURZUVAE. ZURZUVAE ® (zuranolone) capsules, for oral use, CIV Initial U.S. Approval: 2023 | 20260421 |